34562-97-5
- Product Name：Pikamilone
- Molecular Formula：C10H12N2O3
- Purity：99%
- Molecular Weight：208.217
Product Details
Melting Point:210-212oC
Appearance:white crystalline powder
Purity:99%
Buy Quality Pikamilone 34562-97-5 In Stock with Immediately Delivery
- Molecular Formula:C10H12N2O3
- Molecular Weight:208.217
- Appearance/Colour:white crystalline powder
- Vapor Pressure:9.65E-12mmHg at 25°C
- Melting Point:210-212oC
- Boiling Point:522.4 °C at 760 mmHg
- PKA:4.60±0.10(Predicted)
- Flash Point:269.8 °C
- PSA：79.29000
- Density:1.245 g/cm3
- LogP:1.06710
Pikamilone(Cas 34562-97-5) Usage
InChI:InChI=1/C10H12N2O3.Na/c13-9(14)4-2-6-12-10(15)8-3-1-5-11-7-8;/h1,3,5,7H,2,4,6H2,(H,12,15)(H,13,14);/q;+1/p-1
34562-97-5 Relevant articles
Evaluation of isonicotinoyl-γ-aminobutyric acid (GABA) nicotinoyl-GABA as pro-drugs of GABA
Matsuyama,Yamashita,Noda,Goto,Ichimaru,Gomita
, p. 4089 - 4095 (1984)
-
Synthesis and biological evaluation of GABA derivatives able to cross the blood-Brain barrier in rats
Carelli, Vincenzo,Liberatore, Felice,Scipione, Luigi,Giorgioni, Gianfabio,Di Stefano, Antonio,Impicciatore, Mariannina,Ballabeni, Vigilio,Calcina, Francesco,Magnanini, Francesca,Barocelli, Elisabetta
, p. 3765 - 3769 (2003)
Two new GABA derivatives, 1 and 2, were ...
COMPOSITIONS AND METHODS FOR THE TREATMENT MIGRAINE AND NEUROLOGIC DISEASES
-
, (2015/06/10)
The invention relates to the compounds o...
PRODRUGS OF GABA ANALOGS
-
Paragraph 0023-0024, (2013/03/26)
The disclosures herein provide compounds...
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROPATHIC PAIN
-
Paragraph 00139; 00140, (2013/12/03)
The invention relates to the compounds o...
NOVEL COMPOSITIONS FOR REDUCING A? 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD)
-
Page/Page column 52; 53, (2011/08/08)
Novel small molecule compounds for reduc...
34562-97-5 Process route
-
-
121667-28-5
nicotinoyl chloride
-
-
34562-97-5
N-nicotinoyl-gamma-aminobutyric acid
| Conditions | Yield |
|---|---|
|
With
palladium 10% on activated carbon; hydrogen;
In
methanol;
at 20 ℃;
for 2h;
Inert atmosphere;
|
90% |
|
With
palladium 10% on activated carbon; hydrogen;
In
methanol;
at 20 ℃;
for 2h;
|
90% |
|
With
hydrogen;
palladium on activated charcoal;
|
-
![4-[(pyridine-3-carbonyl)amino]butyric acid methyl ester](/upload/2024/8/a8408368-158c-4852-a890-72115b7f3bb6.png)
-
4-[(pyridine-3-carbonyl)amino]butyric acid methyl ester
-
-
34562-97-5
N-nicotinoyl-gamma-aminobutyric acid
| Conditions | Yield |
|---|---|
|
4-[(pyridine-3-carbonyl)amino]butyric acid methyl ester;
With
water; lithium hydroxide;
In
tetrahydrofuran;
at 25 - 45 ℃;
With
hydrogenchloride;
In
water;
pH=2 - 3;
|
80% |
34562-97-5 Upstream products
-
553-53-7
Nicotinic acid hydrazide
-
56-12-2
4-amino-n-butyric acid
-
24690-42-4
p-Nitrophenyl nicotinate
-
20260-53-1
pyridine-3-carbonyl chloride hydrochloride
34562-97-5 Downstream products
-
75319-77-6
p-nitrophenyl 4-nicotinamidobutyrate
-
59-67-6
nicotinic acid
-
56-12-2
4-amino-n-butyric acid
-
1316665-23-2
4-[(pyridine-3-carbonyl)amino]butyric acid 4-allyl-2-methoxyphenyl ester
Relevant Products
-
Epinephrine HydrochlorideCAS：329-63-5
-
PterostilbeneCAS：537-42-8
-
Lutein ester
CAS：247-17-1
